ASCEND: A Randomised, double-blinded phase II study of gemcitabine and nab‐paclitaxel with CEND‐1 or placebo in patients with untreated metastatic pancreatic ductal adenocarcinoma

  • Harris, Marion (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date15/07/22 → 31/10/24

Keywords

  • Randomised clinical trial
  • phase 2 study
  • pancreatic cancer
  • treatment efficacy